StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) stock

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ocean Biomedical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Ocean Biomedical's operating income for the twelve months ending Mar 31, 2025 was -$4.16M. For fiscal 2024 it was -$3.80M.

Annual operating income

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$3.80M–
FY2023Dec 31, 2023-$10.21M–
FY2022Dec 31, 2022-$16.12M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025-$958.00K–
Q4 FY2024Dec 31, 2024-$1.75M-365.6%
Q3 FY2024Sep 30, 2024-$768.00K–
Q2 FY2024Jun 30, 2024-$682.00K–
Q1 FY2024Mar 31, 2024-$595.00K–
Q4 FY2023Dec 31, 2023$660.00K–
Q3 FY2023Sep 30, 2023-$2.66M–
Q2 FY2023Jun 30, 2023-$2.83M–
Q1 FY2023Mar 31, 2023-$5.39M–
Q4 FY2022Dec 31, 2022-$938.00K–
Q3 FY2022Sep 30, 2022-$3.17M–
Q2 FY2022Jun 30, 2022-$6.90M–
Q1 FY2022Mar 31, 2022-$5.11M–
Q3 FY2021Sep 30, 2021-$42.80K–

More Ocean Biomedical figures

See a number that looks wrong?